Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-002442
Filing Date
2020-01-31
Accepted
2020-01-31 16:51:56
Documents
1
Period of Report
2020-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4040
  Complete submission text file 0000899243-20-002442.txt   5499
Mailing Address OSI PHARMACEUTICALS, INC. 41 PINELAWN ROAD MELVILLE NY 11747
Business Address
Epstein David M. (Reporting) CIK: 0001488668 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 20565704

Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)